Clinical Trial: Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Latisse(Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Brief Summary: The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost .03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period.

Detailed Summary:
Sponsor: Kenneth Beer

Current Primary Outcome: Efficacy of Latisse applied to the lateral and medial eyebrow [ Time Frame: 10 months ]

Increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Beer, Kenneth R., M.D., PA

Dates:
Date Received: July 1, 2011
Date Started: March 2011
Date Completion:
Last Updated: June 14, 2012
Last Verified: June 2012